SCHEMBL8401989

SCHEMBL8401989

O=Nc1cc(O)cc2cccnc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 10/20 0.54
HSP90AB1 P08238 9/20 0.54
KDM4E B2RXH2 5/20 0.50
TDP1 Q9NUW8 5/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
MAPT P10636 3/20 0.50
ALDH1A1 P00352 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
XBP1 P17861 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MMP2 P08253 2/20 0.43
TSHR P16473 2/20 0.43
NFKB1 P19838 2/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CHRM1 P11229 1/20 0.43
COMT P21964 1/20 0.43
ADRA1A P35348 1/20 0.43
METAP2 P50579 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12047072 0.81 SLC40A1 (0.46) HSP90AA1HSP90AB1KDM4ETDP1NPC1
SCHEMBL12047079 0.79 PSMD14 (0.57) HSP90AA1KDM4ETDP1NPC1RAB9A
SCHEMBL8581634 0.76 KDM4E (0.54) HSP90AA1KDM4ETDP1NPC1RAB9A
SCHEMBL11808148 0.76 COMT (0.61) HSP90AA1HSP90AB1KDM4ETDP1NPC1
SCHEMBL8401986 0.76 CYP1A2 (0.61) HSP90AA1HSP90AB1KDM4ETDP1RAB9A
SCHEMBL7897309 0.74 KDM4E (0.56) HSP90AA1KDM4ETDP1NPC1RAB9A
SCHEMBL3688928 0.74 L3MBTL1 (0.56) HSP90AA1HSP90AB1KDM4ETDP1NPC1
SCHEMBL8401985 0.73 CYP3A4 (0.51) HSP90AA1KDM4ENPC1RAB9AALDH1A1
SCHEMBL8404766 0.73 TOP1 (0.44) HSP90AA1HSP90AB1KDM4ETDP1NPC1
SCHEMBL14242732 0.73 HSP90AA1 (0.54) HSP90AA1HSP90AB1KDM4ETDP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 HSP90AA1 2256/4885HSP90AB1 1565/4885KDM4E 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.